Yüklüyor......
Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder
Lithium is the mainstay prophylactic treatment for bipolar disorder (BD), but treatment response varies considerably across individuals. Patients who respond well to lithium treatment might represent a relatively homogeneous subtype of this genetically and phenotypically diverse disorder. Here, we p...
Kaydedildi:
| Yayımlandı: | Mol Psychiatry |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4995544/ https://ncbi.nlm.nih.gov/pubmed/26503763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mp.2015.165 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|